van der Boor, Saskia C.
Alkema, Manon
van Gemert, Geert-Jan
Teelen, Karina
van de Vegte-Bolmer, Marga
Walk, Jona
van Crevel, Reinout
de Mast, Quirijn
Ockenhouse, Christian F.
Sauerwein, Robert W.
McCall, Matthew B. B.
Funding for this research was provided by:
PATH's Malaria Vaccine Initiative
Article History
Received: 6 September 2022
Accepted: 15 February 2023
First Online: 7 April 2023
Declarations
:
: The study protocol (file number NL63594.091.17) and its amendments were approved by the Netherlands’ Central Committee on Research Involving Human Subjects , and the Western Institutional Review Board. All study participants consented to trial inclusion.
: Not applicable.
: The authors declare they have no competing interests.